"Translating" tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways
- PMID: 16849518
- DOI: 10.1158/1541-7786.MCR-06-0150
"Translating" tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways
Abstract
Poor oxygenation (hypoxia) is present in the majority of human tumors and is associated with poor prognosis due to the protection it affords to radiotherapy and chemotherapy. Hypoxia also elicits multiple cellular response pathways that alter gene expression and affect tumor progression, including two recently identified separate pathways that strongly suppress the rates of mRNA translation during hypoxia. The first pathway is activated extremely rapidly and is mediated by phosphorylation and inhibition of the eukaryotic initiation factor 2alpha. Phosphorylation of this factor occurs as part of a coordinated endoplasmic reticulum stress response program known as the unfolded protein response and activation of this program is required for hypoxic cell survival and tumor growth. Translation during hypoxia is also inhibited through the inactivation of a second eukaryotic initiation complex, eukaryotic initiation factor 4F. At least part of this inhibition is mediated through a Redd1 and tuberous sclerosis complex 1/2-dependent inhibition of the mammalian target of rapamycin kinase. Inhibition of mRNA translation is hypothesized to affect the cellular tolerance to hypoxia in part by promoting energy homeostasis. However, regulation of translation also results in a specific increase in the synthesis of a subset of hypoxia-induced proteins. Consequently, both arms of translational control during hypoxia influence gene expression and phenotype. These hypoxic response pathways show differential activation requirements that are dependent on the level of oxygenation and duration of hypoxia and are themselves highly dynamic. Thus, the severity and duration of hypoxia can lead to different biological and therapeutic consequences.
Similar articles
-
Hypoxia and regulation of messenger RNA translation.Methods Enzymol. 2007;435:247-73. doi: 10.1016/S0076-6879(07)35013-1. Methods Enzymol. 2007. PMID: 17998058
-
Translational control of gene expression during hypoxia.Cancer Biol Ther. 2006 Jul;5(7):749-55. doi: 10.4161/cbt.5.7.2972. Epub 2006 Jul 1. Cancer Biol Ther. 2006. PMID: 16861930 Review.
-
The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth.Cancer Biol Ther. 2006 Jul;5(7):723-8. doi: 10.4161/cbt.5.7.2967. Epub 2006 Jul 1. Cancer Biol Ther. 2006. PMID: 16861899 Review.
-
ER stress, hypoxia tolerance and tumor progression.Curr Mol Med. 2006 Feb;6(1):55-69. doi: 10.2174/156652406775574604. Curr Mol Med. 2006. PMID: 16472113 Review.
-
Control of the hypoxic response through regulation of mRNA translation.Semin Cell Dev Biol. 2005 Aug-Oct;16(4-5):487-501. doi: 10.1016/j.semcdb.2005.03.009. Semin Cell Dev Biol. 2005. PMID: 15896987 Review.
Cited by
-
Protein aggregation and biomolecular condensation in hypoxic environments (Review).Int J Mol Med. 2024 Apr;53(4):33. doi: 10.3892/ijmm.2024.5357. Epub 2024 Feb 16. Int J Mol Med. 2024. PMID: 38362920 Free PMC article. Review.
-
The crosstalk among the physical tumor microenvironment and the effects of glucose deprivation on tumors in the past decade.Front Cell Dev Biol. 2023 Nov 1;11:1275543. doi: 10.3389/fcell.2023.1275543. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38020920 Free PMC article. Review.
-
Tumor microenvironmental nutrients, cellular responses, and cancer.Cell Chem Biol. 2023 Sep 21;30(9):1015-1032. doi: 10.1016/j.chembiol.2023.08.011. Epub 2023 Sep 12. Cell Chem Biol. 2023. PMID: 37703882 Review.
-
Ca2+-Dependent Effects of the Selenium-Sorafenib Nanocomplex on Glioblastoma Cells and Astrocytes of the Cerebral Cortex: Anticancer Agent and Cytoprotector.Int J Mol Sci. 2023 Jan 26;24(3):2411. doi: 10.3390/ijms24032411. Int J Mol Sci. 2023. PMID: 36768736 Free PMC article.
-
Activating transcription factor 4 regulates hypoxia inducible factor 1α in chronic hypoxia in pancreatic cancer cells.Oncol Rep. 2023 Jan;49(1):14. doi: 10.3892/or.2022.8451. Epub 2022 Nov 23. Oncol Rep. 2023. PMID: 36416348 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources